Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Patients With Postherpetic Neuralgia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Cubist Pharmaceuticals.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Pfizer
Information provided by:
Cubist Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01058642
First received: January 27, 2010
Last updated: June 6, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2011
  Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)